Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.48 -0.01 (-2.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Pasithea Therapeutics (KTTA) reported Return on Capital Employed [ROCE] of -45.90% for Q2 2026, up 51.68 percentage points from -97.57% a year earlier but down 7.08 percentage points from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Pasithea Therapeutics posted Return on Capital Employed [ROCE] of -62.86%, up 8.49 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a four-year change of -45.75 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -71.35% in FY2024 (-22.95 pp), -48.40% in FY2023 (-21.83 pp), -26.57% in FY2022 (-9.46 pp) and -17.11% in FY2021.
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -100.89% in Q1 2025 and a high of -12.27% in Q4 2021.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last three quarters, with an average year-over-year change of +3.32 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2026 (a gain of 62.07 percentage points); the low point was Q2 2024 (a drop of 51.34 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -38.82% (Q1 2026), -65.26% (Q4 2025) and -99.41% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Pasithea Therapeutics 16.04 Mn 16.04 Mn - -45.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -45.90%
Mar 31, 2026 -38.82%
Dec 31, 2025 -65.26%
Sep 30, 2025 -99.41%
Jun 30, 2025 -97.57%
Mar 31, 2025 -100.89%
Dec 31, 2024 -87.79%
Sep 30, 2024 -92.28%
Jun 30, 2024 -90.79%
Mar 31, 2024 -77.11%
Dec 31, 2023 -62.05%
Sep 30, 2023 -45.96%
Jun 30, 2023 -39.45%
Mar 31, 2023 -33.07%
Dec 31, 2022 -28.37%
Sep 30, 2022 -21.74%
Jun 30, 2022 -16.14%
Mar 31, 2022 -12.29%
Dec 31, 2021 -12.27%
API Access

Pasithea Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KTTA&period=max&api_key=YOUR_API_KEY